Radial Access Data in Vascular Interventions Registry
- Sponsor
- Mersin Medicalpark Hastanesi
- Study ID
- NCT07614386
- Status
- Recruiting
Conditions
- Coronary Artery Disease
- Peripheral Arterial Disease
- Radial Artery Occlusion
- Radial Artery Spasm
- Vascular Access Complications
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Radial and Ulnar Artery Access — PROCEDURERoutine percutaneous vascular interventions performed via radial or ulnar artery access according to standard clinical practice.
Study Details
The RADIUS study is a prospective observational registry designed to collect real-world data regarding radial and ulnar artery access in percutaneous vascular interventions. The study aims to evaluate procedural characteristics, access-site complications, procedural success, and short-term clinical outcomes associated with transradial and transulnar vascular access. Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access at Mersin Medical Park Hospital will be consecutively enrolled. Demographic, clinical, angiographic, procedural, and post-procedural data will be prospectively collected and analyzed. The study was initially designed as a single-center registry; however, following Institutional Review Board (IRB) approval, expansion into a multicenter registry with participating centers is planned. This study is observational in nature and does not involve any experimental treatment, device, or intervention beyond standard clinical care.
Key Dates
- First listed
- May 29, 2026
- Start date
- May 15, 2026
- Status verified
- Jun 2026
- Primary completion
- Dec 31, 2030
- Completion
- May 20, 2031
Study Design
- Enrollment
- 20,000 participants (estimated)
Arms
- Arm: Radial and Ulnar Access Registry CohortPatients undergoing routine percutaneous vascular interventions via radial or ulnar artery access.
Primary Outcome Measure
Radial Artery Occlusion Rate [ Time Frame: Within 1 year after procedure ]
Central Contacts
- Sefa SURAL, MD+90 532 565 01 60
- Gökhan AVCI, MD+90 506 228 57 09
Related Studies
- Evaluating Cardiovascular Phenotypes Using Induced Pluripotent Stem CellsEnrolling By Invitation · Scripps Translational Science Institute · La Jolla, California
- Product Surveillance RegistryRecruiting · Medtronic · Birmingham, Alabama
- Efficacy and Saftey Study of 99mTc-ECDG in the Evaluation of Coronary Artery Disease (CAD)PHASE2 · Not Yet Recruiting · Cell>Point LLC · Oklahoma City, Oklahoma
- Multi-Center Registry for Peripheral Arterial Disease Interventions and OutcomesRecruiting · Baylor Research Institute · Detroit, Michigan